온도 제어 의약품 포장 솔루션 시장 예측(-2030년) : 포장 유형별, 온도 범위별, 소재별, 적재량별, 용도별, 지역별 세계 분석

According to Stratistics MRC, the Global Temperature Controlled Pharma Packaging Solutions Market is accounted for $4.91 billion in 2024 and is expected to reach $7.29 billion by 2030 growing at a CAGR of 6.8% during the forecast period. Temperature-controlled pharma packaging solutions are specialized systems designed to maintain specific temperature ranges for pharmaceutical products during transportation and storage. These solutions are essential for safeguarding the integrity and efficacy of temperature-sensitive drugs, vaccines, biologics, and other healthcare products. They include insulated packaging, active cooling or heating systems, and temperature monitoring devices that ensure compliance with regulatory standards.

Market Dynamics:

Driver:

Rising demand for biopharmaceuticals

The rising demand for biopharmaceuticals is primarily driven by the increase in chronic diseases, aging populations, and advancements in biotechnology. These factors necessitate efficient, reliable, and compliant packaging solutions to maintain the efficacy and safety of biopharmaceutical products throughout the supply chain. With the growth in personalized medicine, the need for specialized packaging that ensures temperature control has become more critical. Additionally, regulatory standards for the storage and transportation of biopharmaceuticals are becoming more stringent, further driving the demand for high-quality packaging solutions.

Restraint:

High packaging and transportation costs

Specialized materials and technologies required for maintaining optimal temperatures during transit contribute to the increased costs. Small and medium-sized pharmaceutical companies, in particular, may find it difficult to bear these expenses, impacting their competitiveness. Furthermore, the need for advanced monitoring systems to ensure compliance with regulatory standards adds to the financial burden. The overall supply chain costs, including storage, handling, and last-mile delivery, are also higher for temperature-sensitive products. These factors can limit the widespread adoption of temperature-controlled packaging solutions, especially in price-sensitive markets.

Opportunity:

Growing incidences of chronic diseases

The growing incidences of chronic diseases such as diabetes, cardiovascular diseases, and cancer present a significant opportunity for the Temperature Controlled Pharma Packaging Solutions Market. As the global population ages, the prevalence of these conditions is expected to rise, leading to increased demand for biopharmaceuticals and other temperature-sensitive treatments. Technological advancements in packaging materials and designs also offer opportunities for innovation and market growth. Additionally, the expanding healthcare infrastructure in emerging markets is creating new opportunities for temperature-controlled packaging providers.

Threat:

Complexity in supply chain management

Advanced monitoring systems, reliable infrastructure, and exact coordination are necessary for managing a temperature-sensitive supply chain. Failure to maintain the necessary temperature ranges may lead to financial losses, non-compliance with regulations, and impaired product quality. Additionally, the global nature of the pharmaceutical supply chain involves multiple stakeholders, including manufacturers, logistics providers, and healthcare institutions, adding to the complexity. The need for real-time visibility and traceability further complicates the supply chain management. These challenges can hinder the efficient distribution of temperature-sensitive pharmaceuticals, impacting patient safety and market growth.

Covid-19 Impact

The Covid-19 pandemic significantly impacted the Temperature Controlled Pharma Packaging Solutions Market. The global supply chain disruptions and lockdown measures affected the production and distribution of pharmaceutical products. However, the demand for temperature-controlled packaging solutions surged. The pandemic also accelerated the adoption of digital monitoring systems to ensure compliance with regulatory standards and maintain the integrity of temperature-sensitive products. Additionally, the increased focus on healthcare infrastructure and preparedness for future pandemics is expected to drive long-term growth in the market.

The active packaging segment is expected to be the largest during the forecast period

The active packaging segment is expected to account for the largest market share during the forecast period. Active packaging solutions, such as refrigerated containers and temperature-controlled boxes, offer advanced features like real-time temperature monitoring and control. The growing demand for biologics and personalized medicine further drives the adoption of active packaging solutions. Additionally, advancements in active packaging technologies, including reusable and sustainable options, contribute to market growth.

The biopharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the biopharmaceuticals segment is predicted to witness the highest growth rate, due to the increasing demand for biologic drugs and personalized medicine. The rise in chronic diseases and advancements in biotechnology are driving the demand for biopharmaceuticals, thereby boosting the need for specialized packaging. Additionally, regulatory agencies' focus on ensuring the safe transportation of these sensitive products is promoting the adoption of temperature-controlled packaging solutions.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to the region's expanding pharmaceutical and biotechnology industries. The increasing demand for temperature-sensitive pharmaceuticals, driven by the rising prevalence of chronic diseases and a growing middle-class population, is boosting the market. Additionally, the region's focus on improving healthcare infrastructure and expanding access to quality healthcare is driving the adoption of temperature-controlled packaging solutions.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the rising demand for sustainable and eco-friendly packaging solutions, in line with strict environmental regulations. The rise in e-commerce and the growing food and beverage sector further contribute to market growth. The advancements in packaging technology and the emphasis on strong, durable packaging to improve brand appeal are also driving the adoption of innovative packaging solutions.

Key players in the market

Some of the key players profiled in the Temperature Controlled Pharma Packaging Solutions Market include Sonoco Products Company, Cold Chain Technologies, LLC, Va-Q-Tec AG, Pelican BioThermal LLC, Softbox Systems, Sofrigam SA, DGP Intelsius GmbH, Inmark, LLC, Envirotainer AB, FedEx Corporation, United Parcel Service, Inc. (UPS), AmerisourceBergen Corporation, Mondi Group, Snyder Industries, and H.B. Fuller Company.

Key Developments:

In December 2024, Sonoco Products Company announced it has entered into an agreement to sell its Thermoformed and Flexibles Packaging business to TOPPAN Holdings Inc. for approximately $1.8 billion on a cash-free and debt-free basis and subject to customary adjustments.

In October 2024, Cold Chain Technologies ("CCT"), a leading global provider of advanced thermal packaging and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, announced it has acquired Tower Cold Chain ("Tower"), a global provider of advanced passive reusable cold chain solutions. Terms of the transaction were not disclosed.

Packaging Types Covered:

• Active Packaging
• Insulated Packaging
• Passive Packaging
• Temperature Monitoring Devices
• Other Packaging Types

Temperature Ranges Covered:

• Cold Temperature Range
• Frozen Temperature Range
• Controlled Room Temperature

Materials Covered:

• Phase Change Materials
• Insulation Materials

Payload Capacities Covered:

• Up to 10 L
• 10 L - 20 L
• 20 L - 40 L
• 40 L - 150 L
• Above 150 L

Applications Covered:

• Biopharmaceuticals
• Pharmaceutical Drugs
• Clinical Trials
• Over-the-Counter (OTC) Products
• Vaccines & Biologics
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Temperature Controlled Pharma Packaging Solutions Market, By Packaging Type

• 5.1 Introduction
• 5.2 Active Packaging
• 5.3 Insulated Packaging
• 5.4 Passive Packaging
• 5.5 Temperature Monitoring Devices
• 5.6 Other Packaging Types

6 Global Temperature Controlled Pharma Packaging Solutions Market, By Temperature Range

• 6.1 Introduction
• 6.2 Cold Temperature Range
• 6.3 Frozen Temperature Range
• 6.4 Controlled Room Temperature

7 Global Temperature Controlled Pharma Packaging Solutions Market, By Material

• 7.1 Introduction
• 7.2 Phase Change Materials
• 7.3 Insulation Materials

8 Global Temperature Controlled Pharma Packaging Solutions Market, By Payload Capacity

• 8.1 Introduction
• 8.2 Up to 10 L
• 8.3 10 L - 20 L
• 8.4 20 L - 40 L
• 8.5 40 L - 150 L
• 8.6 Above 150 L

9 Global Temperature Controlled Pharma Packaging Solutions Market, By Application

• 9.1 Introduction
• 9.2 Biopharmaceuticals
• 9.3 Pharmaceutical Drugs
• 9.4 Clinical Trials
• 9.5 Over-the-Counter (OTC) Products
• 9.6 Vaccines & Biologics
• 9.7 Other Applications

10 Global Temperature Controlled Pharma Packaging Solutions Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Sonoco Products Company
• 12.2 Cold Chain Technologies, LLC
• 12.3 Va-Q-Tec AG
• 12.4 Pelican BioThermal LLC
• 12.5 Softbox Systems
• 12.6 Sofrigam SA
• 12.7 DGP Intelsius GmbH
• 12.8 Inmark, LLC
• 12.9 Envirotainer AB
• 12.10 FedEx Corporation
• 12.11 United Parcel Service, Inc. (UPS)
• 12.12 AmerisourceBergen Corporation
• 12.13 Mondi Group
• 12.14 Snyder Industries
• 12.15 H.B. Fuller Company